151 related articles for article (PubMed ID: 31640343)
1. Energetics of Flap Opening in HIV-1 Protease: String Method Calculations.
Gardner JM; Abrams CF
J Phys Chem B; 2019 Nov; 123(45):9584-9591. PubMed ID: 31640343
[TBL] [Abstract][Full Text] [Related]
2. Curling of flap tips in HIV-1 protease as a mechanism for substrate entry and tolerance of drug resistance.
Scott WR; Schiffer CA
Structure; 2000 Dec; 8(12):1259-65. PubMed ID: 11188690
[TBL] [Abstract][Full Text] [Related]
3. Interaction of I50V mutant and I50L/A71V double mutant HIV-protease with inhibitor TMC114 (darunavir): molecular dynamics simulation and binding free energy studies.
Meher BR; Wang Y
J Phys Chem B; 2012 Feb; 116(6):1884-900. PubMed ID: 22239286
[TBL] [Abstract][Full Text] [Related]
4. Flap-site Fragment Restores Back Wild-type Behaviour in Resistant Form of HIV Protease.
Luchi A; Angelina E; Bogado L; Forli S; Olson A; Peruchena N
Mol Inform; 2018 Dec; 37(12):e1800053. PubMed ID: 30051611
[TBL] [Abstract][Full Text] [Related]
5. A contribution to the drug resistance mechanism of darunavir, amprenavir, indinavir, and saquinavir complexes with HIV-1 protease due to flap mutation I50V: a systematic MM-PBSA and thermodynamic integration study.
Leonis G; Steinbrecher T; Papadopoulos MG
J Chem Inf Model; 2013 Aug; 53(8):2141-53. PubMed ID: 23834142
[TBL] [Abstract][Full Text] [Related]
6. Structural and binding insights into HIV-1 protease and P2-ligand interactions through molecular dynamics simulations, binding free energy and principal component analysis.
Karnati KR; Wang Y
J Mol Graph Model; 2019 Nov; 92():112-122. PubMed ID: 31351319
[TBL] [Abstract][Full Text] [Related]
7. Binding of single walled carbon nanotube to WT and mutant HIV-1 proteases: analysis of flap dynamics and binding mechanism.
Meher BR; Wang Y
J Mol Graph Model; 2012 Sep; 38():430-45. PubMed ID: 23142620
[TBL] [Abstract][Full Text] [Related]
8. Explicit solvent dynamics and energetics of HIV-1 protease flap opening and closing.
Sadiq SK; De Fabritiis G
Proteins; 2010 Nov; 78(14):2873-85. PubMed ID: 20715057
[TBL] [Abstract][Full Text] [Related]
9. Exploring the flap dynamics of the South African HIV subtype C protease in presence of FDA-approved inhibitors: MD study.
Maphumulo SI; Halder AK; Govender T; Maseko S; Maguire GEM; Honarparvar B; Kruger HG
Chem Biol Drug Des; 2018 Nov; 92(5):1899-1913. PubMed ID: 30003668
[TBL] [Abstract][Full Text] [Related]
10. Exploring the drug resistance of V32I and M46L mutant HIV-1 protease to inhibitor TMC114: flap dynamics and binding mechanism.
Meher BR; Wang Y
J Mol Graph Model; 2015 Mar; 56():60-73. PubMed ID: 25562662
[TBL] [Abstract][Full Text] [Related]
11. Closing of the flaps of HIV-1 protease induced by substrate binding: a model of a flap closing mechanism in retroviral aspartic proteases.
Tóth G; Borics A
Biochemistry; 2006 May; 45(21):6606-14. PubMed ID: 16716071
[TBL] [Abstract][Full Text] [Related]
12. Dynamic flaps in HIV-1 protease adopt unique ordering at different stages in the catalytic cycle.
Karthik S; Senapati S
Proteins; 2011 Jun; 79(6):1830-40. PubMed ID: 21465560
[TBL] [Abstract][Full Text] [Related]
13. Multi-drug resistance profile of PR20 HIV-1 protease is attributed to distorted conformational and drug binding landscape: molecular dynamics insights.
Chetty S; Bhakat S; Martin AJ; Soliman ME
J Biomol Struct Dyn; 2016; 34(1):135-51. PubMed ID: 25671669
[TBL] [Abstract][Full Text] [Related]
14. Structural Studies of a Rationally Selected Multi-Drug Resistant HIV-1 Protease Reveal Synergistic Effect of Distal Mutations on Flap Dynamics.
Agniswamy J; Louis JM; Roche J; Harrison RW; Weber IT
PLoS One; 2016; 11(12):e0168616. PubMed ID: 27992544
[TBL] [Abstract][Full Text] [Related]
15. Structural studies on molecular mechanisms of Nelfinavir resistance caused by non-active site mutation V77I in HIV-1 protease.
Gupta A; Jamal S; Goyal S; Jain R; Wahi D; Grover A
BMC Bioinformatics; 2015; 16 Suppl 19(Suppl 19):S10. PubMed ID: 26695135
[TBL] [Abstract][Full Text] [Related]
16. Flap opening mechanism of HIV-1 protease.
Tóth G; Borics A
J Mol Graph Model; 2006 May; 24(6):465-74. PubMed ID: 16188477
[TBL] [Abstract][Full Text] [Related]
17. Conformational flexibility in the flap domains of ligand-free HIV protease.
Heaslet H; Rosenfeld R; Giffin M; Lin YC; Tam K; Torbett BE; Elder JH; McRee DE; Stout CD
Acta Crystallogr D Biol Crystallogr; 2007 Aug; 63(Pt 8):866-75. PubMed ID: 17642513
[TBL] [Abstract][Full Text] [Related]
18. Insights into the dynamics of HIV-1 protease: a kinetic network model constructed from atomistic simulations.
Deng NJ; Zheng W; Gallicchio E; Levy RM
J Am Chem Soc; 2011 Jun; 133(24):9387-94. PubMed ID: 21561098
[TBL] [Abstract][Full Text] [Related]
19. Drug pressure selected mutations in HIV-1 protease alter flap conformations.
Galiano L; Ding F; Veloro AM; Blackburn ME; Simmerling C; Fanucci GE
J Am Chem Soc; 2009 Jan; 131(2):430-1. PubMed ID: 19140783
[TBL] [Abstract][Full Text] [Related]
20. Flap opening in HIV-1 protease simulated by 'activated' molecular dynamics.
Collins JR; Burt SK; Erickson JW
Nat Struct Biol; 1995 Apr; 2(4):334-8. PubMed ID: 7796268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
